文献速递衰弱、肌少症与跌倒老年综合评估多重用药

门诊老年患者衰弱与肌少症筛查及其与医疗负担的关联

Screening for Frailty and Sarcopenia Among Older Persons in Medical Outpatient Clinics and its Associations With Healthcare Burden.
PubMed 文献 · J Am Med Dir Assoc · 2017-02-24

本研究在新加坡国立大学医院专科门诊对115名65岁及以上患者进行横断面调查,使用Edmonton衰弱量表和SARC-F问卷筛查衰弱与肌少症。结果显示肌少症患病率44.3%、衰弱27.0%,两者均与更高共病指数、需照护者、多重用药、多次专科随访、反复住院及跌倒相关,且显著降低自评健康状态。

要点

  • 门诊老年患者中肌少症患病率44.3%,衰弱27.0%,两者重叠常见。
  • 衰弱与肌少症均与多重用药、反复住院、多次专科随访及跌倒相关。
  • 筛查有助于早期识别高危患者并及时干预以减轻医疗负担。

核心结论

  • 门诊老年患者衰弱与肌少症患病率高,两者可预测反复住院、多重用药、多次专科预约、跌倒及严重跌倒后果。

研究设计与样本

  • 横断面研究,纳入2015年5月至2016年2月新加坡国立大学医院专科门诊就诊的115名65岁及以上患者。

主要发现

  • 44.3%(n=51)患者为肌少症,27.0%(n=31)为衰弱,23.5%(n=27)同时存在衰弱与肌少症。
  • 87.1%的衰弱患者合并肌少症,47.1%的肌少症患者合并衰弱。
  • 衰弱和肌少症与更高Charlson共病指数、需照护者、更多专科随访、多重用药、一年内超过2次住院、更多跌倒及严重跌倒后果相关。
  • 50.0%的健壮患者自评健康为极好,肌少症患者为19.6%(P < .001),衰弱患者为9.7%(P < .001),衰弱合并肌少症患者最低为3.7%(P < .001)。

关键数值与推荐

  • 使用Edmonton衰弱量表识别衰弱,使用SARC-F问卷识别肌少症。

临床怎么用

  • 在老年医学科门诊可使用Edmonton衰弱量表和SARC-F问卷筛查衰弱与肌少症,识别高风险患者并及时干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: With an aging population and increase in multimorbidity, the importance of screening for frailty and sarcopenia has become a public health priority. Several tools to do so exist. This study aimed to examine whether the SARC-F and Edmonton frail screening tools are useful in clinical practice to identify at-risk patients for negative health outcomes who would benefit from intervention. DESIGN: This is a cross-sectional study of patients attending medical specialist outpatient clinics at the National University Hospital, Singapore from May 2015 to February 2016. MEASUREMENTS: Frailty and sarcopenia were identified using the Edmonton Frail Scale and SARC-F questionnaires, respectively. Other clinically relevant data including basic demographics, presence of caregiver, number of follow-ups, medications and hospital readmissions in the past 1 year, Charlson comorbidity index, and modified Barthel index were collected from chart review. RESULTS: A total of 115 patients 65 years old and older were screened. Of the sample, 44.3% (n = 51) of patients were sarcopenic, whereas 27.0% (n = 31) were classified as frail; 23.5% (n = 27) were both frail and sarcopenic; and 87.1% of frail patients were sarcopenic, whereas 47.1% of sarcopenic patients were frail. Sarcopenia and frailty were associated with a higher Charlson comorbidity index, higher likelihood of requiring a caregiver, more medical specialty follow-ups, polypharmacy, more than 2 hospital admissions within a year, a higher number of falls and falls with serious consequences. This affected their perceived health status with 50.0% of robust patients rating their health excellent compared with 19.6% of sarcopenic patients (P < .001), 9.7% of frail patients (P < .001) and sarcopenic and frail patients scoring the lowest with 3.7% (P < .001). CONCLUSIONS: The prevalence of frailty and sarcopenia among older adults attending medical outpatient clinic is high. Both syndromes are predictors of recurrent hospital admissions, polypharmacy, multiple medical clinic appointments, higher rate of falls, and falls with serious consequences. Early identification of older adults at risk of adverse health outcomes would aid in instituting timely intervention to reduce healthcare burden and improve quality of life.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Tan LF, Lim ZY, Choe R, et al. Screening for Frailty and Sarcopenia Among Older Persons in Medical Outpatient Clinics and its Associations With Healthcare Burden. J Am Med Dir Assoc. 2017. PMID: 28242192. doi:10.1016/j.jamda.2017.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。